We apologize for any inconveniences as the site is being expanded with new modules & functionalities being added.

BREAKING NEWS
Cancer
Keeping you updated with all the latest developments, researches, drug trials and treatment protocols for cancer. For detailed information about cancer including cancer types, cancer treatments, cancer drugs, cancer care and also the best cancer hospitals and cancer doctors in Thailand, please visit our other website: www.thailandcancerhelp.com
Source: Cancer Treatments  Jul 12, 2020  3 days ago
Cancer Treatments: Oncology researchers from Stanford University and Washington State University have demonstrated that a fatty acid called dihomogamma-linolenic acid, or DGLA, can be used to target and kill human cancer cells.   The research findings published in the journal: Developmental Cell, found that DGLA can induce ferroptosis in an animal model and in actual human cancer cells...
Source: Medical Fund Raising Project  Jun 28, 2020  17 days ago
HELP! Medical Fund Raising Project: Sale Of Artworks We urgently need your help for various needs from expanding this site, and procuring medical supplies for various charity projects we manage. We have a series of paintings from the famed Canadian artist: Bruneau,Kittie who is a member of the Royal Canadian Academy of Arts  and at 91, her paintings are displayed in various famous museums a...
Source: Prostate Cancer  Jun 28, 2020  17 days ago
Prostate Cancer: A international collaborative study led by researchers from Carolina Urologic Research Center-South Carolina and involving  more than 15 medical entities from around the world spanning Tokyo, France, Canada etc, has demonstrated that the use of oral relugolix in men with prostate cancer may help to achieve rapid, sustained suppression of testosterone levels as compared to inj...
Source: Liver Cancer  Jun 27, 2020  18 days ago
Liver Cancer: Researchers from Sanford Burnham Prebys Medical Institute and Weill Cornell School Of Medical Sciences at Cornell University have  discovered an enzyme that blocks metabolic processes and contribute to the rapid growth and spread of liver cancer.   The research findings, published in Cancer Cell, could spur development of new therapies for a type of cancer that has b...
Source: Breast Cancer  Jun 26, 2020  19 days ago
Breast Cancer: A new study by researchers from San Diego State University has found that cancer survivors have a reduced capacity to process highly acidic foods and such foods can actually increase the risk of recurrence or even mortality. Foods such as fresh and processed meats, cheese, eggs, sugary food, soft drinks, and grains are acid-producing foods and they produce sulfuric, phosphoric, or o...
Source: Lung Cancer  Jun 24, 2020  21 days ago
Lung Cancer: A new study by Swiss researches show that blocking a pair of sugar-transporting proteins may be a useful treatment approach for lung cancer as it could help slow the growth of tumors.   It is a well-known fact that cancer cells use a lot of sugar to fuel their rapid growth and spread.   Hence this has led scientists to consider cutting off their sugar supply as a way to tr...
Source: Photodynamic Therapy  Jun 22, 2020  23 days ago
Photodynamic Therapy: Oncology researchers from Kazan Federal University and Medical Center of the Presidential Administration of Kazakhstan have found that Photodynamic therapy is a useful treatment option for metastatic ovarian cancer.   Their research findings was published in the journal: BioNano Science https://link.springer.com/article/10.1007/s12668-020-00749-7   PDT or Photodyn...
Source: Immunotherapy and Vitamin D  Jun 22, 2020  23 days ago
Immunotherapy: Researchers from Harvard Medical School in new study they recently conducted are saying that taking vitamin D supplements may help prevent a potentially serious side effect of a revolutionary form of anti-cancer therapy known as immunotherapy. This is typical side-effect is the inflammation of the colon or colitis. Therapeutically, immune checkpoint inhibitors help the immune ...
Source: Prostate Cancer  Jun 21, 2020  24 days ago
Prostate Cancer:  Pre-clinical trials by the University of South Australia indicate that reformulation of the prostate cancer drug abiraterone acetate improves the drug's effectiveness by 40 per cent and dramatically improve the quality of life for individuals suffering from prostate cancer.   The research findings have been published in the International Journal of Pharmaceutics. ...
Source: Chemotherapy, Doxirubicin And Heart Failure  Jun 20, 2020  25 days ago
Chemotherapy: Medical researchers from Yale have developed a technique to predict whether cancer patients receiving a common chemotherapy drug are likely to experience heart failure as a result.   Doxorubicin, a chemotherapy drug which is often used to treat a number of cancers, including breast and bladder cancers, lymphoma, and Kaposi's sarcoma also has some negative side-effects of w...
Source: Breast Cancer  Jun 18, 2020  27 days ago
Breast Cancer: A new research by oncologists from the University of Notre Dame-Indiana  shows that statins which are drugs used to treat high cholesterol could interfere with the way breast cancer cells adapt to the microenvironment in the brain, preventing the cancer from taking hold. Patients with breast cancer who experience this type of metastasis typically survive for only months after d...
Source : Mesothelioma and Cancer  Jun 15, 2020  1 month ago
Mesothelioma: According to a cancer research abstract presented during a virtual session of the Society of Interventional Radiology's 2020 Annual Scientific Meeting held yesterday by cancer researchers from Moffitt Cancer Center in Florida and also the University of South Florida, a novel treatment for advanced mesothelioma is safe and effective and may improve the quality of life for patients...
Source: Aspirin and Cancer  Jun 13, 2020  1 month ago
Aspirin and Cancer: Oncology and medical researchers have discovered from an international clinical trial that a regular dose of aspirin taken to reduce the risk of inherited bowel cancer can have long lasting effects even up to 10 years after stopping treatment. The clinical trial known as CAPP2 involved patients with Lynch syndrome from around the world and revealed that two aspirins a day, for ...
Source: Aspirin And Cancer  Jun 09, 2020  1 month ago
Aspirin: A detailed meta-analysis by Italian researchers involving more than 113 past cancer studies indicates that by taking one or two aspirin doses a week helps ward off cancer, especially liver, stomach, pancreatic and bowel cancer. However they warned that while taking aspirin reduces the risk of cancer, it can increase the risk of ulcers and stomach bleeding and no one should ever start taki...
Source: Chemotherapy  Jun 03, 2020  1 month ago
Chemotherapy: Medical and oncology researchers from University Of Virginia in a new study found that what a cancer patient eats can affect the outcome of chemotherapy. The same can be applied to other patients with other chronic conditions and the corresponding medical treatments.   The research paper was published in the journal: Nature Communications. https://www.nature.com/articles/s4146...
Source: Immunotherapy  Jun 02, 2020  1 month ago
Immunotherapy: A research led by medical scientists from the Ohio State University Comprehensive Cancer Center has identified a protein called PCBP1 within certain immune cells that is required for optimal immune responses to cancer.   The study findings, reported in the journal Science Advances, also suggest that the protein might be useful for predicting which cancer patients&nb...
Source: ASCO20 Cancer Updates  May 30, 2020  2 months ago
ASCO20 Cancer Updates:  Medical researchers from the University College London (UCL) and University College London Hospitals NHS Foundation Trust (UCLH) in a recent large  international clinical trial have found that pembrolizumab, a form of immunotherapy, more than doubled the 'progression free survival' time of patients with a specific subtype of advanced bowel cancer, when com...
Source: Cancer Diagnostics  May 29, 2020  2 months ago
Cancer Diagnostics: Biotech and medical researchers from the University of Birmingham are developing a new type of diagnostic test that uses complex sugars to detect prostate cancer earlier and with greater accuracy.   The new diagnostic test works by identifying sugars, known as glycans, in blood. These sugars are attached to protein molecules called PSA and are known to undergo ...
Source: Brain Cancer  May 27, 2020  2 months ago
Brain Cancer: Researchers from Virginia Commonwealth University Massey Cancer Center and Institute of Molecular Medicine (VIMM) have reported that lumefantrine, an FDA-approved drug used to treat malaria has demonstrated effectiveness to enhance existing treatment protocols to treat Glioblastoma multiforme (GBM), an aggressive form of cancer in the brain that is typically fatal.   The resea...
Source: Breast Cancer  May 26, 2020  2 months ago
Breast Cancer: Oncology researchers from University Of South Australia have made a significant breakthrough by discovering how an obscure protein causes breast cancer to develop and grow more quickly.   According to Associate Professor Dr Michael Samuel, a senior University Of South Australia researcher in the Centre for Cancer Biology (CCB), who spearheaded this research with co-lead scien...
Source: Cancer News  May 18, 2020  2 months ago
Cancer:  Medical and oncology researchers from the University of Eastern Finland have developed a new and promising pharmaceutical compound for the treatment of cancer that inhibits natural amino acids from entering cancer cells. Since amino acids are critical for the growth and division of cancer cells, the new LAT1 inhibitor makes it possible to inhibit the growth of cancer cells.   ...
Source: Cancer News  May 13, 2020  2 months ago
Cancer News: Medical and oncology researchers from University Of Southern California and the IFOM Cancer Institute in Milan have found that a fasting-mimicking diet could be more effective at treating some types of cancer including colorectal cancers when combined with vitamin C.   In research on animal models, the team found that the combination delayed tumor progression in multiple animal...
Source : Cancer News  May 05, 2020  2 months ago
Cancer: Oncology researchers at the University of Alberta are enhancing a breast cancer therapy by improving how the treatment is delivered.   Dr Hasan Uludag, a Professor in chemical and materials engineering, and his team have developed a chemical compound that allows them to effectively inject genetic material into cells. https://www.liebertpub.com/doi/10.1089/hum....
Source: Covid-19 News  Mar 27, 2020  4 months ago
According to a research letter published online March 25 in JAMA Oncology, patients with cancer in Wuhan had an increased risk for severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infections. The journal warns that similar issues could also affect cancer patients elsewhere. (https://jamanetwork.com/journals/jamaoncology/fullarticle/2763673)   Dr Jing Yu, M.D., from the Zhon...
Source: Thailand Medical News  Feb 01, 2020  6 months ago
A new year-by-year age meta-analysis of colorectal cancer rates among U.S. adults and also adults globally finds a 46% increase in new diagnoses from ages 49 to 50, indicating that many latent cases of the disease are likely going undiagnosed until routine screenings begin at 50, according to a new study in JAMA Network Open. Lead study author Dr. Jordan Karlitz, associate clinical professo...
Source: Thailand Medical News  Jan 31, 2020  6 months ago
A new research study by oncology researchers at the University Of California Los Angeles Jonsson Comprehensive Cancer Center suggests that using an immunotherapy drug called NKTR-214, also known as bempegaldesleukin, in combination with an infusion of anti-tumor immune cells, or T cells, may produce a stronger immune response that could help fight advanced melanoma.   The researchers told T...
Source: Thailand Medical News  Jan 29, 2020  6 months ago
Medical and oncology researchers at the Johns Hopkins Kimmel Cancer Center in Baltimore, working with colleagues in the Netherlands, have developed a new ultrasensitive blood test that can predict recurrence of gastric cancer in patients after surgery. A description of their test, which is still experimental, was published online in the journal Nature Communications.   The medical inve...
Source: Thailand Medical News  Jan 19, 2020  6 months ago
Medical scientists at the University of Glasgow and Cancer Research UK Beatson Institute have tested close to 1000 existing medicines and discovered that a cheap drug commonly used to treat parasitic worm infection could be a game-changing treatment for prostate cancer. Prostate cancer is the most common cancer affecting men and the second most common cause of cancer death for men globally. &nbs...
Source: Thailand Medical News  Jan 18, 2020  6 months ago
Researchers from New Ohio State University have shown an association between breast cancer survivors' use of proton pump inhibitors (PPIs) and reports of problems with concentration and memory. On average, cognitive problems reported by PPI users were between 20 and 29 percent more severe than issues reported by non-PPI users. PPIs are sold under such brand names as Nexium, Prevacid ...
Source: Thailand Medical News  Dec 26, 2019  7 months ago
A new investigational cancer drug that targets tumors caused by mutations in the KRAS gene will be evaluated in phase 2 clinical trials, following promising safety and efficacy results in preliminary human studies and excellent results in animal studies. The drug, developed by Amgen and currently referred to as AMG 510, is the first therapy to reach clinical trials that inhibits a mutant KRAS prot...
Source: Thailand Medical News  Dec 21, 2019  7 months ago
Prostate Cancer According to a new University College of London-led computer modelling study, nearly one in six deaths from prostate cancer could be prevented if targeted screening was introduced for men at a higher genetic risk of the disease. Prostate cancer is the most common form of cancer in men with around 1.3 million new cases diagnosed globally each year and more than 400,000 men a yea...
Source: Thailand Medical News  Dec 19, 2019  7 months ago
Medical researchers at Children's Medical Center Research Institute at University Of Texas Southwestern (CRI) have uncovered why certain melanoma cells are more likely to spread through the body. The discovery opens up a potential new avenue of treatment and could be used to help reduce the proportion of patients who progress from stage 3 melanoma to more-deadly stage 4 cancer. Dr. Sean Mor...
Source: Thailand Medical News  Dec 15, 2019  7 months ago
Scientists from QIMR Berghofer Medical Research Institute, Brisbane have discovered a potential new cancer immunotherapy target that involves switching off a regulatory cell to stop tumors growing and spreading. The new study findings have been published today in Cancer Discovery, a journal of the American Association for Cancer Research. Associate Professor Dr Michele Teng, senior resear...
Source: Thailand Medical News  Dec 10, 2019  7 months ago
Oncologists who treat patients with the aggressive triple negative breast cancer have two new ways to predict which cancer patients may benefit most from the well-established post-surgery treatment known as AC chemotherapy, short for adjuvant doxorubicin and cyclophosphamide. Oncology researchers from the SWOG Cancer Research Network, a cancer clinical trials network funded by the National Canc...
Source: Thailand Medical News  Dec 05, 2019  7 months ago
Though prostate cancer is the most common cancer in men globally, we still have yet to know all of its causes. The largest ever study to use genetics as a measurement for physical activity to look at its effect on prostate cancer, reveals that being more active reduces the risk of prostate cancer. Over 140,000 men were included in the study, of which, 80,000 had prostate cancer. The study, publ...
Source: Thailand Medical News  Dec 04, 2019  7 months ago
A Phase 11 clinical trial involving a pioneering precision medicine already licensed for breast and ovarian cancer can also slow or stop tumour growth in some men with advanced prostate cancer. The recently concluded phase II trial found that over 80 per cent of men with prostate cancer whose tumours had mutations in the BRCA genes responded well to treatment with the target...
Source: Thailand Medical News  Nov 30, 2019  8 months ago
Researchers from the University Of Buffalo have developed a new, portable breast imaging system that has the potential to better identify breast cancer in women with dense breast tissue. That is among the findings of a study published in the journal IEEE Transactions on Biomedical Engineering . The research study was led by University at Buffalo researchers in collaboration with Roswell...
Source: Thailand Medical News  Nov 30, 2019  8 months ago
Dr. David P. Labbé, a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), and his colleagues were recently able to discover what molecular events occur for prostate cancer to progress faster and to be deadlier when patients eat a high-fat diet in an extensive research study. In a study published in Nature Communications, they showed that saturated f...
Source: Thailand Medical News  Nov 28, 2019  8 months ago
Flavonoids which are phytochemicals found in fruits and vegetables, can help prevent colorectal cancer. Though studies conducted during the last 20 years have established this, scientists have struggled to determine how flavonoids are responsible for cancer prevention. Associate professor Jayarama Gunaje, left, and doctoral student Ranjini Sankaranarayanan of the Department of Pharmaceutical Sci...
Source: Thailand Medical News  Nov 28, 2019  8 months ago
Typically, it is a feeling that many who receive a cancer diagnosis can identify with: heartbreak and fear, followed by hopes that chemotherapy will save the day. Unfortunately, for many patients, chemo's painful side effects cause them to stop treatment prematurely. Fortunately, a research team headed by Professor Alexander Binshtok, head of the Pain Plasticity Research Group at the Hebrew U...
Source: Thailand Medical News  Nov 27, 2019  8 months ago
University of Western Ontario are conducting a new clinical study that looks to move doctors and patients closer to earlier and more precise detection of recurrent prostate cancer that would clarify treatment decisions and lead to more confident courses of action and better health outcomes. The multi-center trial registry testing the use of a new imaging tracer ie the prostate specific membrane a...
Source: Thailand Medical News  Nov 27, 2019  8 months ago
A new research by Peter MacCallum Cancer Centre has shed new light on why men are more likely than women to get cancer, uncovering a new role for the X chromosome in affecting cancer risk and mortality. While males are known to have a higher risk of developing, and dying from, cancer compared to women even when matched for other known cancer risk factors like age, race, smoking histor...
Source: Thailand Medical News  Nov 26, 2019  8 months ago
Globally, more than 1,180 individuals are diagnosed with pancreatic cancer each day. Within 12 months of diagnosis, 85% will die from it as its one of the most deadly cancers. Despite being lethal, a new research from the University of South Australia could help vastly improve the prognosis for pancreatic cancer patients. Utilizing  a new targeted radioimmunotherapy agent, UniSA Prof...
Source: Thailand Medical News  Nov 25, 2019  8 months ago
Lynparza or Olaparib, is a pharmacological inhibitor of the enzyme PARP (poly ADP Ribose polymerase or PARP) which is required for cancer cell DNA repair. In the presence of certain mutations like BRCA1 and BRCA2, Olaparib kills cancer cells. Olaparib is typically used to treat women suffering from ovarian and breast cancers, has shown promising results when administered to men in whom pro...
Source: Thailand Medical News  Nov 23, 2019  8 months ago
Overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma (HCC) significantly improves with a combination therapy using PD-L1 inhibitor atezolizumab (an immunotherapy drug)  and the VEGF inhibitor bevacizumab,  according to results from a phase 3 study reported at the ESMO Asia 2019 Congress. Dr Ann-Lii Cheng, Director of the National Taiwan...
Source: Thailand Medical News  Nov 22, 2019  8 months ago
Medical researchers from the University of Luxembourg together with researchers from the Integrated Biobank of Luxembourg (IBBL) and oncologists from the Centre Hospitalier Emile Mayrisch (CHEM) are in the process of developing a kit which could facilitate the detection of colorectal cancer at early stage and help clinicians choose the best treatment. Dr. Elisabeth Letellier, principal investig...
Source: Thailand Medical News  Nov 21, 2019  8 months ago
Thailand Cancer News Researchers from the University of Granada (UGR), the Institute of Nanoscience of Aragon (INA), the University of Zaragoza, and the Cancer Research UK Edinburgh Centre at the University of Edinburgh in a collaborative research and study are using “Trojan horses” to combat cancer from within the tumour cells themselves without damaging healthy tissues is the aim of...
Source: Thailand Medical News  Nov 21, 2019  8 months ago
Thailand Cancer News A joint research study by  Cold Spring Harbor Laboratory scientists along with chemists and cancer biologists from Dana-Farber Cancer Institute (DFCI), have developed a new therapy that extended the survival of mice with acute myeloid leukemia. The researchers are the first to demonstrate the anti-cancer effect of blocking the Salt-Inducible Kinase 3 (SIK3) pathway in...
Source: Thailand Medical News  Nov 21, 2019  8 months ago
Thailand Cancer News The University of Barcelona (UB) and Hospital Clínic de Barcelona entered into a collaboration with pharma giant, Boehringer Ingelheim Inc to improve the efficiency of nintedanib, an antiangiogenic and antifibrotic drug, for the treatment of lung cancer. This public-private collaboration enabled researchers  to identify molecular mechanisms underlying the lack of ...
Source: Thailand Medical News  Nov 21, 2019  8 months ago
Thailand Cancer A recent study by A QIMR Berghofer, a medical research institute in Queensland, Australia has identified how a newly approved blood cancer drug works and found the treatment is better than other drugs at targeting cancer stem cells while causing minimal damage to healthy cells. In mid-2018, the long-acting form of the drug Interferon alpha was approved for use in Australia...
Source: Thailand Medical News  Nov 19, 2019  8 months ago
A new study by researchers from the gastroenterology team at Henri-Mondor AP-HP Hospital and University Paris-Est Créteil, led by Professor Iradj Sobhani, together with teams from Inserm and the Institut Pasteur Molecular Microbial Pathogenesis Unit (U1202), led by Professor Philippe Sansonetti,holder of the Microbiology and Infectious Diseases Chair at the Collège de France,have dem...
Source: Thailand Medical News  Nov 13, 2019  8 months ago
Researchers at Purdue University have come up with a way to combine the anthrax toxin with a growth factor to kill bladder cancer cells and tumors. Anthrax may soon help more people win the fight against bladder cancer, which the Centers for Disease Control and Prevention says strikes about 72,000 Americans each year and kills about 16,000 and is one of the most expensive cancers to treat....
Source: Thailand Medical News  Nov 12, 2019  8 months ago
A new joint study by the University of Leeds and the University of Aberdeen have identified potential environmental risk factors and new targets for treating an aggressive form of breast cancer.The  new data was presented at the Society for Endocrinology annual conference in Brighton. The study suggests that exposure to common chemicals in our everyday environment may increase the risk of dev...
Source: Thailand Medical News  Nov 05, 2019  8 months ago
As a result of a growing incidence rate of colorectal cancer in the US and also globally, the American College of Physicians (ACP) has issued new revised guidelines that has been published in the Annals Of Internal Medicine.   The guidelines states that doctors should screen for colorectal cancer in average-risk adults who do not have symptoms between the ages of 50 and 75. The frequency of...
Source: Thailand Medical News  Nov 03, 2019  8 months ago
A new study led by Rice University bioscientist Dr Natashat Kirienko and postdoctoral researcher Svetlana Panina found that mitocans, anti-cancer drugs that target mitochondria, are particularly adept at killing leukemia cells, especially when combined with a glycolytic inhibitor, while leaving healthy blood cells in the same sample largely unaffected. The published findings, an open ...

MOST READ

Source: COVID-19 Blood Clots
May 20, 2020  2 months ago
Source : Thailand Medical news
Feb 05, 2020  5 months ago

Interesting Reads

Source: COVID-19 Convalescent Plasma and Hyperimmune Plasma Or H-Ig Therapies
Jun 15, 2020  1 month ago
Source: Nitric Oxide and COVID-19
Jun 15, 2020  1 month ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  1 month ago
Source: COVID-19 Long-Term Health Implications
Jun 13, 2020  1 month ago
Source: COVID-19, Influenza and Next Wave
Jun 10, 2020  1 month ago
Source: Myocardial Injury
Jun 09, 2020  1 month ago
Source: Hartmann-Boyce, Jamie & Lindson, Nicola – Converzation
Jun 03, 2020  1 month ago
Source: COVID-19 News
May 21, 2020  2 months ago
Source: Covid-19 Treatments And Drugs News
Mar 20, 2020  4 months ago
Source: SARS-Cov-2 Coronavirus Research
Mar 08, 2020  4 months ago
Source : Thailand Medical News
Feb 11, 2020  5 months ago
Source: Thailand Medical News
Feb 10, 2020  5 months ago
Source: Thailand Medical News
Feb 09, 2020  5 months ago